{"transactions":[{"id":732120,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":36822,"kind":"person","name":"Kariuki Enoch","position":1,"cik":"0001843119","reported_name":"Kariuki Enoch","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T20:07:01.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":57100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 16, 2027 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date."}],"balance_after":194465,"source":{"system":"sec-edgar","filing":"0001843119-26-000003","document":"wk-form4_1781813217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000184311926000003/wk-form4_1781813217.xml","form_type":"4"}},{"id":1106356,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":36822,"kind":"person","name":"Kariuki Enoch","position":1,"cik":"0001843119","reported_name":"Kariuki Enoch","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-18T20:14:02.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":57603,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 17, 2026 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date."}],"balance_after":137365,"source":{"system":"sec-edgar","filing":"0001725160-25-000131","document":"wk-form4_1750277634.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516025000131/wk-form4_1750277634.xml","form_type":"4"}},{"id":1472110,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":36822,"kind":"person","name":"Kariuki Enoch","position":1,"cik":"0001843119","reported_name":"Kariuki Enoch","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-21T21:09:42.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":41581,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 21, 2025 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date."}],"balance_after":79762,"source":{"system":"sec-edgar","filing":"0001725160-24-000143","document":"wk-form4_1719004175.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516024000143/wk-form4_1719004175.xml","form_type":"4"}},{"id":1852372,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":36822,"kind":"person","name":"Kariuki Enoch","position":1,"cik":"0001843119","reported_name":"Kariuki Enoch","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T21:02:38.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":16364,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 16, 2024 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date."}],"balance_after":38181,"source":{"system":"sec-edgar","filing":"0001725160-23-000143","document":"wk-form4_1686949344.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516023000143/wk-form4_1686949344.xml","form_type":"4"}},{"id":2056255,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":36822,"kind":"person","name":"Kariuki Enoch","position":1,"cik":"0001843119","reported_name":"Kariuki Enoch","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-11T16:19:47.000Z","date":"2023-01-11","kind":"disposition_to_issuer","acquired":false,"shares":11904,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 19, 2022, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\"), by and among the Issuer, Merck Sharpe & Dohme LLC and M-Inspire Merger Sub, Inc., providing for the merger of M-Inspire Merger Sub, Inc. with and into the Issuer (the \"Merger\"), with the Issuer surviving as a wholly owned subsidiary of Merck Sharpe & Dohme LLC. Pursuant to the Merger Agreement, each option to purchase common stock of the Issuer, whether vested or unvested, outstanding immeditately prior to the effective time of the Merger, were exchanged for a cash payment equal to (x) the aggregate number of shares of the Issuer's common stock subject to such option, multiplied by (y) the excess, if any, of $36.00 over the per share exercise price under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 19, 2022, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\"), by and among the Issuer, Merck Sharpe & Dohme LLC and M-Inspire Merger Sub, Inc., providing for the merger of M-Inspire Merger Sub, Inc. with and into the Issuer (the \"Merger\"), with the Issuer surviving as a wholly owned subsidiary of Merck Sharpe & Dohme LLC. Pursuant to the Merger Agreement, each option to purchase common stock of the Issuer, whether vested or unvested, outstanding immeditately prior to the effective time of the Merger, were exchanged for a cash payment equal to (x) the aggregate number of shares of the Issuer's common stock subject to such option, multiplied by (y) the excess, if any, of $36.00 over the per share exercise price under such option."}],"balance_after":0,"derivative":{"exercise_price":15.65,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":11904},"source":{"system":"sec-edgar","filing":"0000899243-23-001607","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623715/000089924323001607/doc4.xml","form_type":"4"}},{"id":2056254,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":36822,"kind":"person","name":"Kariuki Enoch","position":1,"cik":"0001843119","reported_name":"Kariuki Enoch","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-11T16:19:47.000Z","date":"2023-01-11","kind":"disposition_to_issuer","acquired":false,"shares":23809,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 19, 2022, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\"), by and among the Issuer, Merck Sharpe & Dohme LLC and M-Inspire Merger Sub, Inc., providing for the merger of M-Inspire Merger Sub, Inc. with and into the Issuer (the \"Merger\"), with the Issuer surviving as a wholly owned subsidiary of Merck Sharpe & Dohme LLC. Pursuant to the Merger Agreement, each option to purchase common stock of the Issuer, whether vested or unvested, outstanding immeditately prior to the effective time of the Merger, were exchanged for a cash payment equal to (x) the aggregate number of shares of the Issuer's common stock subject to such option, multiplied by (y) the excess, if any, of $36.00 over the per share exercise price under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 19, 2022, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\"), by and among the Issuer, Merck Sharpe & Dohme LLC and M-Inspire Merger Sub, Inc., providing for the merger of M-Inspire Merger Sub, Inc. with and into the Issuer (the \"Merger\"), with the Issuer surviving as a wholly owned subsidiary of Merck Sharpe & Dohme LLC. Pursuant to the Merger Agreement, each option to purchase common stock of the Issuer, whether vested or unvested, outstanding immeditately prior to the effective time of the Merger, were exchanged for a cash payment equal to (x) the aggregate number of shares of the Issuer's common stock subject to such option, multiplied by (y) the excess, if any, of $36.00 over the per share exercise price under such option."}],"balance_after":0,"derivative":{"exercise_price":16,"expiration_date":"2031-07-14","underlying":"Common Stock","underlying_shares":23809},"source":{"system":"sec-edgar","filing":"0000899243-23-001607","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623715/000089924323001607/doc4.xml","form_type":"4"}},{"id":2056253,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":36822,"kind":"person","name":"Kariuki Enoch","position":1,"cik":"0001843119","reported_name":"Kariuki Enoch","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-11T16:19:47.000Z","date":"2023-01-11","kind":"disposition_to_issuer","acquired":false,"shares":119047,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 19, 2022, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\"), by and among the Issuer, Merck Sharpe & Dohme LLC and M-Inspire Merger Sub, Inc., providing for the merger of M-Inspire Merger Sub, Inc. with and into the Issuer (the \"Merger\"), with the Issuer surviving as a wholly owned subsidiary of Merck Sharpe & Dohme LLC. Pursuant to the Merger Agreement, each option to purchase common stock of the Issuer, whether vested or unvested, outstanding immeditately prior to the effective time of the Merger, were exchanged for a cash payment equal to (x) the aggregate number of shares of the Issuer's common stock subject to such option, multiplied by (y) the excess, if any, of $36.00 over the per share exercise price under such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 19, 2022, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\"), by and among the Issuer, Merck Sharpe & Dohme LLC and M-Inspire Merger Sub, Inc., providing for the merger of M-Inspire Merger Sub, Inc. with and into the Issuer (the \"Merger\"), with the Issuer surviving as a wholly owned subsidiary of Merck Sharpe & Dohme LLC. Pursuant to the Merger Agreement, each option to purchase common stock of the Issuer, whether vested or unvested, outstanding immeditately prior to the effective time of the Merger, were exchanged for a cash payment equal to (x) the aggregate number of shares of the Issuer's common stock subject to such option, multiplied by (y) the excess, if any, of $36.00 over the per share exercise price under such option."}],"balance_after":0,"derivative":{"exercise_price":4.2,"expiration_date":"2031-02-04","underlying":"Common Stock","underlying_shares":119047},"source":{"system":"sec-edgar","filing":"0000899243-23-001607","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623715/000089924323001607/doc4.xml","form_type":"4"}},{"id":2236080,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":36822,"kind":"person","name":"Kariuki Enoch","position":1,"cik":"0001843119","reported_name":"Kariuki Enoch","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-10T20:21:14.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":21817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 8, 2023 or (b) the next occurring annual meeting of the Company's stockholders, subject to the Reporting Person's continued service on the Board of Directors through such vesting date."}],"balance_after":21817,"source":{"system":"sec-edgar","filing":"0001725160-22-000120","document":"wf-form4_165489245326140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516022000120/wf-form4_165489245326140.xml","form_type":"4"}},{"id":2243694,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":36822,"kind":"person","name":"Kariuki Enoch","position":1,"cik":"0001843119","reported_name":"Kariuki Enoch","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-03T16:39:30.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":11904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual meeting in 2023 of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":11904,"derivative":{"exercise_price":15.65,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":11904},"source":{"system":"sec-edgar","filing":"0001567619-22-012286","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623715/000156761922012286/doc1.xml","form_type":"4"}},{"id":2630016,"issuer":{"id":15490,"kind":"organization","name":"Imago BioSciences, Inc.","symbol":"IMGO"},"owners":[{"id":36822,"kind":"person","name":"Kariuki Enoch","position":1,"cik":"0001843119","reported_name":"Kariuki Enoch","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-19T16:11:33.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":23809,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One thirty-sixth (1/36th) of the shares initially subject to the option will vest on each monthly anniversary measured from July 15, 2021 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":23809,"derivative":{"exercise_price":16,"expiration_date":"2031-07-14","underlying":"Common Stock","underlying_shares":23809},"source":{"system":"sec-edgar","filing":"0001567619-21-013642","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623715/000156761921013642/doc1.xml","form_type":"4"}},{"id":2869314,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":36822,"kind":"person","name":"Kariuki Enoch","position":1,"cik":"0001843119","reported_name":"Kariuki Enoch","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-10T14:41:30.000Z","date":"2021-02-09","kind":"grant","acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable in substantially equal monthly installments over the 36 months following the date of grant."}],"balance_after":42000,"derivative":{"exercise_price":39.47,"expiration_date":"2031-02-08","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001725160-21-000029","document":"wf-form4_161296807661323.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516021000029/wf-form4_161296807661323.xml","form_type":"4"}}]}